Format

Send to

Choose Destination
Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26371. Epub 2016 Dec 1.

Long-term survivors of childhood bone and soft tissue sarcomas are at risk of hospitalization.

Author information

1
University of Utah School of Medicine, Salt Lake City, Utah.
2
Sarcoma Services, Huntsman Cancer Institute, Salt Lake City, Utah.
3
Department of Orthopaedics, University of Utah, Salt Lake City, Utah.
4
Department of Pediatric Hematology and Oncology, University of Utah, Salt Lake City, Utah.
5
Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
6
Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, Salt Lake City, Utah.
7
Utah Cancer Registry, Salt Lake City, Utah.
8
Pedigree and Population Resource (Utah Population Database), Huntsman Cancer Institute, Salt Lake City, Utah.
9
Department of Family and Consumer Studies, University of Utah, Salt Lake City, Utah.

Abstract

BACKGROUND:

Childhood cancer survivors can have a high burden of chronic conditions related to cancer treatment, some of which are debilitating or potentially life-threatening. Much remains to be learned about late effects in bone and soft tissue sarcoma survivors.

PROCEDURES:

The Utah Cancer Registry was used to identify survivors of bone (N = 71) and soft tissue sarcomas (N = 98) who were diagnosed at ages 0-20 years between 1973 and 2007 and were alive at least 5 years after diagnosis. We selected an age-sex-matched comparison cohort (N = 934). Hospitalizations from 1996 to 2012 were extracted from the Utah Department of Health statewide inpatient hospitalization discharge records. Cox, Poisson, and Gamma regressions were used to evaluate the risk of hospitalization, rate of admission, and length of stay for survivors versus the comparison cohort. Primary ICD-9 codes defined the most common reasons for hospitalizations.

RESULTS:

The hazard ratio (HR) of any hospitalization was higher for survivors in reference to the comparison cohort (HR = 2.12, 95% confidence interval [CI] 1.51-2.97). Survivors experienced more hospital admissions (rate ratio [RR] = 4.58, 95% CI 3.92-5.35) and longer length of stay (RR = 1.28, 95% CI 1.12-1.46) compared with the comparison cohort. Survivors treated with any chemotherapy were at three-fold higher risk (HR = 3.37, 95% CI 1.94-5.83) of hospitalization compared with survivors who received surgery and/or radiation alone. Among hospitalized survivors, the most common reason was injury for bone tumor (26.8%) and neoplasm for soft tissue sarcoma (12.2%).

CONCLUSION:

Childhood survivors of bone tumor and soft tissue sarcoma face ongoing risk of hospitalization for years after diagnosis.

KEYWORDS:

AYA; Utah Population Database; bone and soft tissue sarcoma; child and adolescent cancer; survivorship

PMID:
27905671
DOI:
10.1002/pbc.26371
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center